You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RRMM

Showing 101 - 125 of 174
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Canton (STI-6129)

Recruiting
  • Multiple Myeloma
  • STI-6129
  • Canton, Ohio
    Gabrail Cancer Center
Jun 29, 2022

Relapsed and/or Refractory Multiple Myeloma Trial in Köln (BMS-986453, Fludarabine, Cyclophosphamide)

Not yet recruiting
  • Relapsed and/or Refractory Multiple Myeloma
  • Köln, Germany
    Local Institution - 0017
Dec 4, 2023

Relapsed/Refractory Multiple Myeloma Trial in United States (KITE-585, Cyclophosphamide, Fludarabine)

Terminated
Has Results
  • Relapsed/Refractory Multiple Myeloma
  • KITE-585
  • +2 more
  • Los Angeles, California
  • +8 more
Oct 4, 2022

Multiple Myeloma Trial (Pembrolizumab, Lenalidomide, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • Pembrolizumab
  • +3 more
  • (no location specified)
Mar 12, 2021

Multiple Myeloma Trial in United States (SEA-BCMA, dexamethasone, pomalidomide)

Recruiting
  • Multiple Myeloma
  • Palo Alto, California
  • +10 more
Aug 24, 2022

Multiple Myeloma Trial in Beverly Hills (Elranatamab, Carfilzomib)

Recruiting
  • Multiple Myeloma
  • Beverly Hills, California
    Beverly Hills Cancer Center
Dec 21, 2022

Multiple Myeloma Trial in Worldwide (Selinexor, Bortezomib, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Plantation, Florida
  • +156 more
Nov 23, 2021

AL Amyloidosis Trial in France (Isatuximab)

Recruiting
  • AL Amyloidosis
  • Amiens, France
  • +14 more
Aug 9, 2022

Multiple Myeloma Trial in Boston (BMS-986393, Alnuctamab, Mezigdomide)

Not yet recruiting
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Nov 2, 2023

Relapsed and/or Refractory Multiple Myeloma Trial in Worldwide (AMG 420)

Completed
  • Relapsed and/or Refractory Multiple Myeloma
  • AMG 420
  • Park Ridge, Illinois
  • +9 more
Dec 1, 2022

Multiple Myeloma Trial in Greece, Korea, Republic of, United States (Belantamab mafodotin)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • Tucson, Arizona
  • +21 more
Jul 20, 2022

Multiple Myeloma Trial in Spain (REGN5458, Daratumumab, Carfilzomib)

Recruiting
  • Multiple Myeloma
  • Athens, Greece
  • +8 more
Nov 30, 2022

Multiple Myeloma in Relapse, Multiple Myeloma, Multiple Myeloma of Bone Trial in Worldwide (HPN217)

Recruiting
  • Multiple Myeloma in Relapse
  • +3 more
  • Gilbert, Arizona
  • +17 more
Jul 21, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Carfilzomib, Dexamethasone, Pomalidomide)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 3, 2022

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in Canada, United States (Ixazomib, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Little Rock, Arkansas
  • +23 more
Feb 24, 2022

Long-term KRd in Relapsed and/or Refractory Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Aug 8, 2022

Medicine Called Elranatamab in People With Relapsed Refractory

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jun 30, 2023

Belantamab Mafodotin Care Patterns in Relapsed and/or Refractory

Not yet recruiting
  • Multiple Myeloma
  • Durham, North Carolina
    Duke University Medical Center
Aug 8, 2023

Relapsed/Refractory Multiple Myeloma Trial in Worldwide (AMG 701, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Relapsed/Refractory Multiple Myeloma
  • AMG 701
  • +2 more
  • Scottsdale, Arizona
  • +33 more
Nov 29, 2022

Multiple Myeloma Trial in Leicester (CC-92480, Tazemetostat, BMS-986158)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +9 more
Oct 24, 2022

Multiple Myeloma Trial in Paris (Idecabtagene vicleucel, Not treated)

Active, not recruiting
  • Multiple Myeloma
  • Idecabtagene vicleucel
  • Not treated
  • Paris, France
    DESCAR-T Registry
Nov 27, 2023

Multiple Myeloma Trial in Worldwide (Elranatamab)

Recruiting
  • Multiple Myeloma
  • Fort Collins, Colorado
  • +33 more
Aug 17, 2022

Plasma Cell Myeloma Trial in Czechia, France, United States (Isatuximab)

Completed
  • Plasma Cell Myeloma
  • Scottsdale, Arizona
  • +17 more
Apr 22, 2022

Real-life Current Standards of Care in Relapsed and/or

Completed
  • Multiple Myeloma
  • No intervention
  • Tucson, Arizona
  • +85 more
Dec 20, 2022

Multiple Myeloma Trial in United Kingdom (Ixazomib, Cyclophosphamide, Dexamethasone)

Unknown status
  • Multiple Myeloma
  • Birmingham, United Kingdom
  • +17 more
Jan 21, 2020